J. Goldman & CO LP Royalty Pharma PLC Transaction History
J. Goldman & CO LP
- $2.89 Billion
- Q1 2024
A detailed history of J. Goldman & CO LP transactions in Royalty Pharma PLC stock. As of the latest transaction made, J. Goldman & CO LP holds 265,334 shares of RPRX stock, worth $7 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
265,334Holding current value
$7 Million% of portfolio
0.28%Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
394Shares Held
275MCall Options Held
276KPut Options Held
236K-
Morgan Stanley New York, NY44.2MShares$1.17 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.7MShares$994 Million0.02% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$559 Million0.02% of portfolio
-
Baillie Gifford & CO16.7MShares$439 Million0.4% of portfolio
-
Viking Global Investors LP11.5MShares$303 Million1.33% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.5B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...